Eli Lilly's Taltz and Novartis' Cosentyx have been jockeying for IL-17 inhibitor supremacy with back-and-forth FDA approvals for years. But in the race for a fourth indication, Taltz has come out on ...
After undershooting analyst sales forecasts in the first quarter, Eli Lilly’s psoriasis drug Taltz is on the hot seat in an immunology market packed with blockbusters. Lilly is hoping some new data on ...
Two decades ago, Eli Lilly and Co. boasted just one blockbuster drug: the groundbreaking antidepressant Prozac, which produced $2.8 billion in revenue at its peak in 1998. Over the next few years, the ...
Eli Lilly and Company LLY announced superior efficacy in a head-to-head study evaluating its marketed drug, Taltz (ixekizumab) versus with Johnson & Johnson’s Stelara (ustekinumab) in patients with ...
Eli Lilly and Co. has won federal approval to market its hot-selling anti-inflammatory drug Taltz for another use: treatment of a type of arthritis that does not show any structural body damage on ...
Drug has been cleared for use in patients whose condition is not controlled well enough with conventional therapy The National Institute for Health and Care Excellence (NICE) has recommended Eli Lilly ...
Eli Lilly now has approval for its new psoriasis treatment Taltz on both sides of the Atlantic after the European Commission granted marketing authorisation for the drug. The interleukin-17 (IL-17) ...
Eli Lilly’s Taltz can now compete on a level playing field with Novartis’ rival drug Cosentyx, after picking up a third FDA approval for ankylosing spondylitis. Taltz (ixekizumab) – an interleukin-17 ...
INDIANAPOLIS, March 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application ...
Medicare may cover Taltz (ixekizumab) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Taltz is a brand-name biologic drug that doctors ...
(Reuters) - Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Taltz demonstrated high levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback